RNASEH1 and infection: Both have different challenges, but a common strategy may be to limit virus replication, to allow the adaptive and innate immune systems time to fight the infection.35, 36 A limitation for ASO-based antiviral strategies directly targeting the virus may be the RNase H1-dependent mode of action of gapmer ASOs.